No Detectable Association Between mRNA COVID-19 Vaccines and Facial Paralysis

While several cases of facial paralysis were observed during the phase 3 clinical trials of the mRNA COVID-19 vaccine, a causal relationship could not be established. With the US Food and Drug Administration recommending monitoring of vaccine recipients, the researchers looked at a disproportionality analysis using the WHO’s pharmacovigilance database, VigiBase.

There are two vaccines that protect against polio: IPV and OPV. This vaccine should be given to patients at two months, four months, and 6 to 8 months of age. A booster dose is administered in patients aged 4 to 6 years.

No Association Between Influenza Severity and Pediatric Vaccination Rate

Vaccine effectiveness and severity of current and prior seasons of influenza have demonstrated no association with vaccination rate in children, according to a study published in JAMA Pediatrics. Compared with other pediatric and adolescent vaccines, the influenza vaccination rate remains low in children. Although many reasons may affect whether a child is vaccinated, the extent…

Next post in Pneumonia